About Daniel Lambert
Form D filings for Pathology Watch from 2019 to 2023 list Daniel Lambert as chief executive officer and director.
Daniel Lambert first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel Lambert in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Daniel Lambert works with at each company, as listed on that company's latest Form D.
Pathology Watch Inc. · Form D, Mar 7, 2023
RS
Rick Stratford
Director
SM
Scott Mattivi
Executive officer
MT
Michael Torno
Executive officer and director
AW
Austin Walters
Director
AD
Arjun Desai
Director